Emotional problems and dysregulation in children/youth with <scp>ADHD</scp> : predictive and moderating effects in a randomized controlled trial of methylphenidate and neurofeedback

Background Children and adolescents with Attention‐Deficit/Hyperactivity Disorder (ADHD) often show increased emotional dysregulation (ED) and internalizing emotional problems (iEP). However, the predictive and moderating role of these emotional difficulties in the treatment of ADHD—particularly regarding pharmacological (methylphenidate, MPH) and non‐pharmacological approaches (neurofeedback at home, NF@home)—remains understudied. This study aims to evaluate the effectiveness of MPH and NF@home in reducing iEP/ED in children with ADHD and to assess the predictive role of iEP/ED and neuropsychological executive function (EF) measures in treatment outcomes. Methods The per‐protocol sample included 146 children (7–13 years) diagnosed with ADHD (inattentive or combined type). iEP was measured with the Strengths and Difficulties Questionnaire (SDQ), ED via a dysregulation profile, and EF using the BRIEF and Continuous Performance Test (CPT). ADHD symptoms were assessed using the ADHD Rating Scale IV. Participants were randomized to either the MPH group ( n = 59) or the NF group ( n = 87), which included NF SMR ( n = 72) and NF TBR ( n = 15), based on individual Theta/Beta‐Ratio (TBR). Mixed‐model analyses considered symptom severity at baseline, age, gender, IQ, and study center as covariates. Results All intervention groups showed significant changes in iEP, but with different effects regarding parent (NF SMR : d = −0.396, 95% CI [−0.574, −0.217]; NF TBR : d = −0.367, 95% CI [−0.747, 0.013]; MPH: d = −0.409, 95% CI [−0.603, −0.215]) and teacher ratings (NF SMR : d = −0.211, 95% CI [−0.405, −0.017]; NF TBR : d = −0.639, 95% CI [−1.06, −0.222]; MPH: d = −0.142, 95% CI [−0.340, 0.056]). There was no between‐intervention effect, supported by non‐inferiority analyses. For ED, we also found significant effects for all interventions; however, significantly more pronounced effects were obtained for MPH. Moreover, both prediction models indicated a limited predictive value. Conclusions The findings suggest non‐inferiority of NF versus MPH treating iEP within an ADHD sample. However, due to limited predictive value, no clear clinical guidance can yet be drawn regarding personalized treatment recommendations. Further studies are needed to confirm and extend these findings.

Authors

Institutions

Publication Details

Journal
Journal of Child Psychology and Psychiatry
Published
2026-07-28
DOI
https://doi.org/10.1111/jcpp.70205
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emotional problems and dysregulation in children/youth with ADHD : predictive and moderating effects in a randomized controlled trial of methylphenidate and neurofeedback

Stéphanie Bioulac, Anna Maria Werling, Friederike Tagwerker, Tomas Ros et al.
Journal of Child Psychology and Psychiatry
Attention Deficit Hyperactivity Disorder
article

Emotional problems and dysregulation in children/youth with ADHD : predictive and moderating effects in a randomized controlled trial of methylphenidate and neurofeedback

Stéphanie Bioulac, Anna Maria Werling, Friederike Tagwerker, Tomas Ros, Alexander Häge, Diane Purper‐Ouakil, Hilario Blasco-Fontecilla, Konstantin Mechler, Louis Mayaud, Aurore Bussalb, Yohan Attal, Olivier Revol, Sarah Baumeister, Elisa Bousquet, Renate Drechsler, Allison Goujon, Marie Delhaye, Anna Kaiser, Éric Acquaviva, Tobias Banaschewski, Caroline Menache, Susanne Walitza, Daniel Brandeis, Amelie Bohner, Richard Delorme
article en

Abstract

Background Children and adolescents with Attention‐Deficit/Hyperactivity Disorder (ADHD) often show increased emotional dysregulation (ED) and internalizing emotional problems (iEP). However, the predictive and moderating role of these emotional difficulties in the treatment of ADHD—particularly regarding pharmacological (methylphenidate, MPH) and non‐pharmacological approaches (neurofeedback at home, NF@home)—remains understudied. This study aims to evaluate the effectiveness of MPH and NF@home in reducing iEP/ED in children with ADHD and to assess the predictive role of iEP/ED and neuropsychological executive function (EF) measures in treatment outcomes. Methods The per‐protocol sample included 146 children (7–13 years) diagnosed with ADHD (inattentive or combined type). iEP was measured with the Strengths and Difficulties Questionnaire (SDQ), ED via a dysregulation profile, and EF using the BRIEF and Continuous Performance Test (CPT). ADHD symptoms were assessed using the ADHD Rating Scale IV. Participants were randomized to either the MPH group ( n = 59) or the NF group ( n = 87), which included NF SMR ( n = 72) and NF TBR ( n = 15), based on individual Theta/Beta‐Ratio (TBR). Mixed‐model analyses considered symptom severity at baseline, age, gender, IQ, and study center as covariates. Results All intervention groups showed significant changes in iEP, but with different effects regarding parent (NF SMR : d = −0.396, 95% CI [−0.574, −0.217]; NF TBR : d = −0.367, 95% CI [−0.747, 0.013]; MPH: d = −0.409, 95% CI [−0.603, −0.215]) and teacher ratings (NF SMR : d = −0.211, 95% CI [−0.405, −0.017]; NF TBR : d = −0.639, 95% CI [−1.06, −0.222]; MPH: d = −0.142, 95% CI [−0.340, 0.056]). There was no between‐intervention effect, supported by non‐inferiority analyses. For ED, we also found significant effects for all interventions; however, significantly more pronounced effects were obtained for MPH. Moreover, both prediction models indicated a limited predictive value. Conclusions The findings suggest non‐inferiority of NF versus MPH treating iEP within an ADHD sample. However, due to limited predictive value, no clear clinical guidance can yet be drawn regarding personalized treatment recommendations. Further studies are needed to confirm and extend these findings.

Journal of Child Psychology and Psychiatry
University of Geneva (CH), Université Libre de Bruxelles (BE), Inserm (FR), Institut Charles Sadron (FR), University of Zurich (CH), Heidelberg University (DE), Centre Hospitalier Universitaire de Grenoble (FR), University Hospital Heidelberg (DE), ETH Zurich (CH), Hôpital Femme Mère Enfant (FR), HES-SO Genève (CH), Sociétés, Acteurs, Gouvernement en Europe (FR), Centre Hospitalier Universitaire de Montpellier (FR), University Hospital of Zurich (CH), Centre de recherche en Epidémiologie et Santé des Populations (FR), Central Institute of Mental Health (DE), Universidad Internacional De La Rioja (ES), Hirslanden Clinique des Grangettes (CH), Swiss Integrative Center for Human Health (CH), Hôpital Robert-Debré (FR), Cyceron (FR), University Hospital Ulm (DE), Hôpital Paul-Brousse (FR), Université Grenoble Alpes (FR)
Quality Education
Openalex Percentile: Top 7%
Attention Deficit Hyperactivity Disorder
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.